HNT.L

Huntsworth Plc
Huntsworth PLC - Rule 2.9 Announcement
28th April 2020, 15:53
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 2223L
Huntsworth PLC
28 April 2020
 

 

28 April 2020

                                                         

Huntsworth plc

(Huntsworth or the Company)

Rule 2.9 Announcement

Listing Rule 9.2.6E - Disclosure of Rights Attached to Equity Shares

 

 

Huntsworth plc, the healthcare and communications group, announces that in anticipation of the sanction of the Scheme on 30 April 2020 by the Court in connection with the the recommended cash offer made by Bidco for Huntsworth under Rule 2.7 of the Code on 3 March 2020, the Company has today issued 12,198,835 new ordinary shares of 1p each in the capital of the Company (New Shares) in order to be able to satisfy various employee share awards made under The Huntsworth Long Term Incentive Plan 2016, The Huntsworth 2016 Deferred Share Bonus Plan, The Huntsworth Executive Share Option Scheme 2006 and The Huntsworth Performance Share Plan. The New Shares will rank pari passu with the existing ordinary shares of 1p each. 

 

In accordance with Rule 2.9 of the City Code on Takeovers and Mergers, the Company confirms that, following today's issue of 12,198,835 Huntsworth Shares, it has 383,917,170 ordinary shares of 1 penny each in issue.

 

The Company further confirms that the total number of voting rights in the Company is 383,917,170. The figure of  383,917,170 may be used by shareholders as the denominator for the calculations by which to determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

The International Securities Identification Number for the Huntsworth Shares is GB00B0CRWK29.

 

 

Listing Rule 9.2.6E - Disclosure of Rights Attached to Equity Shares

 

In compliance with Listing Rule 9.2.6E, the Company has forwarded to the FCA for publication a copy of its current Articles of Association, which is the document that sets out the terms and conditions on which its listed equity shares were issued. A copy of the Articles of Association have been submitted to the National Storage Mechanism and will shortly be available for inspection at:  https://data.fca.org.uk/#/nsm/nationalstoragemechanism    

 

 

Unless otherwise defined, all capitalised terms used but not defined in this announcement shall have the meaning given to them in the the circular relating to the Acquisition posted by Huntsworth to Huntsworth Shareholders on 23 March 2020.

 

For further information please contact:

 

Citigate Dewe Rogerson                               

+44 (0)20 7638 9571

Angharad Couch


Nick Reading


Elizabeth Kittle


 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RTTEVLFLBZLEBBF ]]>
TwitterFacebookLinkedIn